NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Calidi Biotherapeutics, Inc. Share Price Chart

O H L

Calidi Biotherapeutics, Inc. Performance Overview

Days Range
$1.07Low
$1.27High

Markets Today

Previous Close$1.27
Open$1.17
Volume190,879
Day's Range$1.07 - $1.27
52W Range$1.16 - $27.84
Market Cap$3.02 M

Historical Performance

1M Returns0.00
3M Returns-53.00
6M Returns-73.54
1Y Returns-94.98
5Y ReturnsNA
10Y ReturnsNA

Calidi Biotherapeutics, Inc. Fundamentals

Market Cap$3.02 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-9.67
EPS TTM$-98.26
Quarterly Earnings Growth YOYN/A
PB Ratio0.78
EBITDA$-18.59 M
Profit MarginN/A
Market Cap$3.02 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-9.67
EPS TTM$-98.26
Quarterly Earnings Growth YOYN/A
PB Ratio0.78
EBITDA$-18.59 M
Profit MarginN/A

Calidi Biotherapeutics, Inc. Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$5.06 M-$5.66 M-$5.05 M-$4.47 M-$4.19 M-$4.15 M
EBITDA -$4.67 M-$5.26 M-$4.62 M-$4.04 M-$3.76 M-$3.71 M
Interest Expense -$72.00 K-$52.00 K-$41.00 K-$42.00 K-$38.00 K-$35.00 K
Depreciation $394.00 K$407.00 K$427.00 K$423.00 K$426.00 K$438.00 K
Income Before Tax -$5.06 M-$5.76 M-$5.17 M-$4.06 M-$4.10 M-$4.16 M
Income Tax Expense $3.00 K$4.00 K$10.00 K-$2.00 K$4.00 K$5.00 K
Net Income +-$5.06 M-$5.76 M-$5.18 M-$4.06 M-$4.11 M-$4.16 M
Net Profit Margin ------

Calidi Biotherapeutics, Inc. Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $3.00 K$0$1.00 K$0$1.00 K$0
Reserve & Surplus -$126.73 M-$132.43 M-$137.58 M-$141.63 M-$145.75 M-$149.91 M
Non-Current Liabilities $2.34 M$1.92 M$1.64 M$1.16 M$820.00 K$834.00 K
Current Liabilities $5.43 M$5.35 M$5.19 M$3.94 M$3.84 M$3.24 M
Total Liabilities $7.76 M$7.28 M$6.83 M$5.10 M$4.66 M$4.07 M
Fixed Assets $795.00 K$929.00 K$849.00 K$781.00 K$758.00 K$775.00 K
Current Assets $11.49 M$6.05 M$11.03 M$6.26 M$7.35 M$5.43 M
Total Assets $15.06 M$9.35 M$14.03 M$8.86 M$9.59 M$7.20 M

Calidi Biotherapeutics, Inc. Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$5.06 M-$5.76 M-$5.18 M-$4.06 M-$4.11 M-$4.16 M
Operating Cash Flow -$7.13 M-$4.88 M-$4.24 M-$5.04 M-$4.12 M-$4.35 M
Investing Cash Flow -$7.00 K-$57.00 K-$27.00 K-$79.00 K-$5.00 K-$33.00 K
Financing Cash Flow $8.11 M-$469.00 K$9.48 M$340.00 K$5.16 M$1.83 M
Change in Cash $970.00 K-$5.40 M$5.21 M-$4.78 M$1.03 M-$2.56 M

Calidi Biotherapeutics, Inc. Return Calculator

The Calidi Biotherapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
Invest in USA Stock Today

About Calidi Biotherapeutics, Inc.

Calidi Biotherapeutics Inc is a biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. The company's proprietary RedTail platform features an engineered enveloped oncolytic virus designed for systemic delivery and targeting of metastatic sites. Its technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis, and deliver potent genetic medicine(s) to metastatic locations. Its product candidates include The RedTail for Metastatic Solid Tumors, CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-101 (NeuroNova) for Newly Diagnosed High Grade Glioma.

FAQs

Calidi Biotherapeutics, Inc. (CLDI) share price as of September 18, 2026 is $1.21. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Calidi Biotherapeutics, Inc. (CLDI) Share by opening an international trading account with Angel One.
Purchasing Calidi Biotherapeutics, Inc. (CLDI) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Calidi Biotherapeutics, Inc. (CLDI) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Calidi Biotherapeutics, Inc. (CLDI) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Calidi Biotherapeutics, Inc. on September 18, 2026, is $3.02 M.
Calidi Biotherapeutics, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Calidi Biotherapeutics, Inc. (CLDI) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91